PTX is administered intraperitoneally at 40 mg/m2 on days 1 and 8. S-1 is administered at 80 mg/m2/day for 14 consecutive days, followed by 7 days rest. Oxaliplatin is administered at 100 mg/m2 on
Sponsors
The University of Tokyo, Jichi Medical University
Conditions
gastric cancer with peritoneal metastasis
Phase 2
Phase II study of intraperitoneal paclitaxel combined with S-1 plus oxaliplatin as second-line chemotherapy for advanced gastric cancer with peritoneal metastasis
Active, not recruitingJPRN-UMIN000012836
Start: 2014-04-01Target: 50Updated: 2026-06-29
Exploratory study of adverse events at the unexperienced hospital in the treatment for gastric cancer with peritoneal metastasis with intraperitoneal paclitaxel combined with S-1 plus oxaliplatin
Active, not recruitingJPRN-UMIN000025501
Start: 2017-05-29Target: 30Updated: 2026-06-29